Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023)
Verano Holdings' (VRNO) quarterly Non-Current Deffered Revenue came in at $255000.0 in Q1 2023, little changed on a QoQ basis from $255000.0 in Q4 2022.
Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023) Analysis & Trends
Verano Holdings (VRNO) has 3 years of Non-Current Deffered Revenue data on file, last reported at $255000.0 in Q1 2023.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $255000.0 in Q1 2023; TTM through Mar 2023 was $255000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $255000.0, down 78.44% from the prior year.
- Non-Current Deffered Revenue for Q1 2023 stood at $255000.0, roughly flat from $255000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for VRNO reached as high as $1.2 million in Q4 2021 and fell as low as $215000.0 in Q3 2022.
- Historically, Non-Current Deffered Revenue has averaged $435800.0 across 3 years, with a median of $255000.0 in 2022.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 78.44% in 2022 and fell as far as 78.44% in 2022.
- Year by year, Non-Current Deffered Revenue stood at $1.2 million in 2021, then plunged by 78.44% to $255000.0 in 2022, then changed by 0.0% to $255000.0 in 2023.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $255000.0 in Q1 2023, $255000.0 in Q4 2022, and $215000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 271,000.00 |
| Dec 31, 2021 | 1.18 Mn |